224
Views
2
CrossRef citations to date
0
Altmetric
Omalizumab treatment in patients with severe chronic spontaneous urticaria: safety consideration from real-life experiences

Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab

, , , &
Pages 2-4 | Received 13 Apr 2018, Accepted 13 Nov 2018, Published online: 08 Jan 2019
 

Abstract

This article reports the rapid and complete remission of concomitant chronic spontaneous urticaria and atopic dermatitis, obtained in a woman of 32 years, after treatment with omalizumab, without adverse events.

Acknowledgement

Medical writing assistance of this paper was provided by Laura Brogelli, on behalf of Content Ed Net; this assistance was funded by Novartis.

Disclosure statement

The authors report no conflicts of interest.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.